Tumor chemosensitivity assays are performed both in the HTS development of new drugs and in finding the best drug to treat the specific form of cancer in a given patient. In the latter case the cancer cells are isolated and cultivated in the absence and presence of various drugs or combinations thereof.
Products: 155-050 Cellular ATP Kit HTS and 188-441 Cell Viability Kit SL
Publications: (Rhedin, A.-S., Tidefelt, U., Jönsson, K., Lundin, A. and Paul, C. (1993) Comparison of a bioluminescent assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells. Leukemia Res. 17, 271-276).